ADVERSE REACTIONS SECTION.
Sincerus Florida, LLC. Adverse reactions. ghv.
Citing DrugCentral © 2026. License
COMPONENTS.
Active, inactive. X.
Citing DrugCentral © 2026. License
INSTRUCTIONS FOR USE SECTION.
Directions for use. w.
Citing DrugCentral © 2026. License
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
NDC 72934-1161-2 NIACINAMIDE USP 4% TAZAROTENE 0.1%. Gel 30gm. f.
Citing DrugCentral © 2026. License